Where Technology meets Opportunity in Science and Engineering
Power At your Finger Tips
Click category or weSRCH domain below to read news from each weSRCH domain
High Tech :- Business, Consumer, Displays, IT, Mobile, Photo, Semiconductors
Medicine :- Biology, Biotech/Pharma, Equipment, Imaging, Implants, Practice Mngmnt, Therapy, Veterinary
Green Tech :- Battery & Fuel, Biomass, Environmental, Fossil/Nuclear, Lighting, Solar, Trans, Wind/Water/Geo
Business :- Companies, Entrepreneurial, IP/Law, Leadership & Strategy, Management, Sales & Marketing, Social Innovation

Latest News, Top News, Breaking News


    Total record(s) 1617 , Page No. 1 , Max 20 Records Per Page -
    Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>
     

    With $550M Fund, Deerfield Management Tackles Early Stage Biotech - Xconomy

      Xconomy Developing lab research into the foundations of a profitable biotech company has always been a high-risk, high-reward business. Deerfield Management, a New York-based healthcare investor with more than $5 billion under m ....more | Save |  Share  Email 28th Jul 2015 
     

    Adults with diabetes more likely to contract TB - Healio

      Medical Xpress Adults with diabetes are up to seven times more likely to contract tuberculosis than the general population, even in countries with a low burden of the infectious disease, according to research in the American Journal of Tropical Me ....more | Save |  Share  Email 28th Jul 2015 
     

    Wakefulness Drug Xyrem Keeps Jazz Pharmaceuticals Up - Nasdaq

      It's sold byJazz Pharmaceuticals ( JAZZ ), which acquired the drug in 2005 when it bought Orphan Medical. At the time, it was approved to treat only cataplexy. Jazz itself had been founded only two years earlier. "We showed it was u ....more | Save |  Share  Email 28th Jul 2015 
     

    IL-Targeted Biologics for Treatment of Psoriasis Show Promising Efficacy - MD Magazine

      Treatment of psoriasis has come a long way in a short time. The development of new biologic drugs that target specific mediators in the immunopathogenesis of plaque psoriasis has transformed management of the disease ....more | Save |  Share  Email 28th Jul 2015 
     

    Carolina Panthers DT Kyle Love determined to not let diabetes define him - Charlotte Observer

      Charlotte Observer Now he's looking to prove diabetes hasn't stopped him. Born in South Korea, Love, 28, grew up in a military family. His father, Anthony, served as a colonel in the U.S. Army, and the ....more | Save |  Share  Email 28th Jul 2015 
     

    Biotech company launched by LA billionaire Soon-Shiong soars on Wall Street - Los Angeles Times

      Los Angeles Times A biotechnology company launched by billionaire Los Angeles doctor Patrick Soon-Shiong is soaring in its initial offering on Wall Street. lRelated NantHealth investment deal paves way for IP ....more | Save |  Share  Email 28th Jul 2015 
     

    Single-Use Technologies for the Biologic Market - Global Industry Size, Trends ... - Medgadget.com (blog)

      Single-use, also known as disposable, refers to products that are intended for one-time use. These products are made from a plastic (polyamide {PA}, polyethylene {PE}, polycarbonate {PC}, polyether ....more | Save |  Share  Email 28th Jul 2015 
     

    ETFs For The Next Pharma Takeover Candidates - Benzinga

      Investors were reminded Monday that the healthcare sector remains this year's premiere destination for large-scale mergers and acquisitions activity when Israel's Teva Pharmaceuticals (NYSE: TEVA) agreed to pay $40.5 billion in cash and st ....more | Save |  Share  Email 28th Jul 2015 
     

    Erectile Dysfunction Linked To Increased Risk Of Type 2 Diabetes - International Business Times

      International Business Times Men with erectile dysfunction, or ED, are at a greater risk of developing type 2 diabetes, a study conducted by researchers at the University of Toronto in Canada suggests. The re ....more | Save |  Share  Email 28th Jul 2015 
     

    ?On the heels of one tiny, eye-focused biotech's success, another plans an IPO - Boston Business Journal (blog)

      Boston Business Journal (blog) Waltham-based EyeGate Pharmaceuticals, which began trading over-the-counter in February, is seeking a $13 million initial public offering this week to swit ....more | Save |  Share  Email 28th Jul 2015 
     

    Hikma Snags Boehringer Ingelheim's US Generics Biz for $2.65 Billion - PharmaLive (press release) (subscription)

      Hikma Pharmaceuticals Plc (HIK.L) said it would buy German drugmaker Boehringer Ingelheim's U.S. specialty generic drugs business for about $2.65 billion in cash and stock ....more | Save |  Share  Email 28th Jul 2015 
     

    Sanofi links with Regeneron in $2.2 billion cancer drug push - PharmaLive (press release) (subscription)

      French drugmaker Sanofi (SASY.PA) said on Tuesday it was committing up to $2.17 billion to a collaboration with its long-time partner Regeneron Pharmaceuticals (REGN.O) in the hot area of cancer imm ....more | Save |  Share  Email 28th Jul 2015 
     

    Growing biotech startup lands new investor - Dayton Business Journal

      Dayton Business Journal Patients' and Consumers Pharma - also known as P&C Pharma - has landed Ohio's Hospice of Dayton as a new investor. This comes following $500,000 in the company received from Accelerant, the venture c ....more | Save |  Share  Email 28th Jul 2015 
     

    New safety warnings for two classes of diabetes drugs: What pharmacists should ... - Pharmacy Today, American Pharmacists Association, pharmacist.com

      Pharmacy Today, American Pharmacists Association, pharmacist.com This spring, FDA called attention to two classes of diabetes drugs and potential serious ....more | Save |  Share  Email 28th Jul 2015 
     

    The changing face of UK pharmaceuticals - Hargreaves Lansdown

      In this article I look at the strategies of the UK's three pharmaceutical giants - GlaxoSmithKline, AstraZeneca and Shire. There are fundamental differences, suggesting very different views of the future. This has important implications ....more | Save |  Share  Email 28th Jul 2015 
     

    French pharmaceutical giant invests at least $1.7 billion in Regeneron cancer drug - Albany Business Review

      Albany Business Review Days after a cholesterol-lowering drug that Regeneron Pharmaceuticals Inc. developed with French company Sanofi won FDA approval, the two companies announced a new partnersh ....more | Save |  Share  Email 28th Jul 2015 
     

    Exercise-mimicking molecule may offer new treatments for obesity, type 2 diabetes - Medical News Today

      Medical News Today "Current treatments for type 2 diabetes center on elevating circulating insulin levels or improving the insulin sensitivity of an individual," says study co-author Dr. Feli ....more | Save |  Share  Email 28th Jul 2015 
     

    Why Progenics Pharmaceuticals' Stock Bolted Higher Today - Motley Fool

      What: Shares of the oncology company Progenics Pharmaceuticals (NASDAQ:PGNX) climbed by as high as 22% in early morning trading today after the company announced that its flagship clinical-stage product, Azedra, was granted Brea ....more | Save |  Share  Email 28th Jul 2015 
     

    Xifin, Translational to Combine Software Products - GenomeWeb

      NEW YORK (GenomeWeb) - Xifin, a healthcare cloud computing company, has signed an agreement with Translational Software to integrate Translational's pharmacogenetics knowledgebase and interpretation platform with Xifin LIS Anywhere, its ....more | Save |  Share  Email 28th Jul 2015 
     

    Heat and diabetes don't mix - Portland Tribune

      As warm temperatures continue this summer, Tualatin Valley Fire & Rescue firefighter paramedics are reminding individuals of all ages to limit their exposure to the sun and heat and take steps to prevent heat-related illnesses. Those who ....more | Save |  Share  Email 28th Jul 2015 
     
    Total record(s) 1617 , Page No. 1 , Max 20 Records Per Page -
    Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>
     
    Subscribe
    x